In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1β, Caspase-3, and Caspase-9 Expression
Mesenchymal stem cells (MSCs) and conditioned medium (CM) derived from human umbilical blood cord stem cells (HUBSC) are now being extensively utilized. Human umbilical vein endothelial cells (HUVECs) have the same ability as HUBSC as an option for autologous therapy. In addition, cell therapy using...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/9/2/48 |
_version_ | 1797476050962219008 |
---|---|
author | Vinny A. Larasati Gregorius V. Lembang Yudy Tjahjono Sugi Winarsih Ika Dewi Ana Hevi Wihadmadyatami Dwi L. Kusindarta |
author_facet | Vinny A. Larasati Gregorius V. Lembang Yudy Tjahjono Sugi Winarsih Ika Dewi Ana Hevi Wihadmadyatami Dwi L. Kusindarta |
author_sort | Vinny A. Larasati |
collection | DOAJ |
description | Mesenchymal stem cells (MSCs) and conditioned medium (CM) derived from human umbilical blood cord stem cells (HUBSC) are now being extensively utilized. Human umbilical vein endothelial cells (HUVECs) have the same ability as HUBSC as an option for autologous therapy. In addition, cell therapy using HUVECs may produce protective signals for cerebral vessels and promote neuronal survival after hypoxic–ischemic damage. HUVECs have the same anatomical and physiological structure as bovine umbilical vein endothelial cells (BUVECs). In this study, we aim to determine the ability of BUVEC-CM to reduce inflammation and apoptosis on in vitro neurodegeneration models (PC12 and SH-SY5Y cell lines). BUVEC-CM obtained from the third and fourth passages were analyzed using liquid chromatography–mass spectrometry (LC-MS) and high-resolution mass spectrometry (HR-MS), while the other part was used as a treatment for in vitro model neurodegeneration. The PC12 and SH-SY5Y cell lines were cultured and grouped into seven different treatments, including untreated cells. As the treatment group, cells were given TMT 10 µM in the presence of different doses of CM (25%, 50%, 75%, and 100%); as a control comparison of recent therapy, donepezil was used. In addition, cells with the administration of TMT 10 µM were run as a positive control. Cell viability assay (CCK-8) and enzyme-linked immunosorbent assay (ELISA) were performed to identify the viability and expression of interleukin-1β (IL-1β), caspase-3, and caspase-9 for both PC12 and SH-SY5Y cells. The results showed that BUVEC-CM could significantly reduce IL-1β expression and downregulate caspase-3 and caspase-9, as well as when compared to the donepezil group. Taken together, these results indicate that BUVEC-CM can be used as a potential candidate for neuroprotective agents by reducing the activity of IL-1β and the expression of caspase-9 and caspase-3 in PC12 and SH-SY5Y cells induced by TMT. However, further research still needs to be conducted. |
first_indexed | 2024-03-09T20:53:25Z |
format | Article |
id | doaj.art-4bd40c23bec84e99947a71f0d2dca412 |
institution | Directory Open Access Journal |
issn | 2306-7381 |
language | English |
last_indexed | 2024-03-09T20:53:25Z |
publishDate | 2022-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Veterinary Sciences |
spelling | doaj.art-4bd40c23bec84e99947a71f0d2dca4122023-11-23T22:27:48ZengMDPI AGVeterinary Sciences2306-73812022-01-01924810.3390/vetsci9020048In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1β, Caspase-3, and Caspase-9 ExpressionVinny A. Larasati0Gregorius V. Lembang1Yudy Tjahjono2Sugi Winarsih3Ika Dewi Ana4Hevi Wihadmadyatami5Dwi L. Kusindarta6Department of Anatomy, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaDepartment of Anatomy, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaBiomedical Laboratory, Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya 60112, IndonesiaDepartment of Agriculture, Food, and Fisheries of Sleman Regency, Yogyakarta 55281, IndonesiaDepartment of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaDepartment of Anatomy, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaDepartment of Anatomy, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaMesenchymal stem cells (MSCs) and conditioned medium (CM) derived from human umbilical blood cord stem cells (HUBSC) are now being extensively utilized. Human umbilical vein endothelial cells (HUVECs) have the same ability as HUBSC as an option for autologous therapy. In addition, cell therapy using HUVECs may produce protective signals for cerebral vessels and promote neuronal survival after hypoxic–ischemic damage. HUVECs have the same anatomical and physiological structure as bovine umbilical vein endothelial cells (BUVECs). In this study, we aim to determine the ability of BUVEC-CM to reduce inflammation and apoptosis on in vitro neurodegeneration models (PC12 and SH-SY5Y cell lines). BUVEC-CM obtained from the third and fourth passages were analyzed using liquid chromatography–mass spectrometry (LC-MS) and high-resolution mass spectrometry (HR-MS), while the other part was used as a treatment for in vitro model neurodegeneration. The PC12 and SH-SY5Y cell lines were cultured and grouped into seven different treatments, including untreated cells. As the treatment group, cells were given TMT 10 µM in the presence of different doses of CM (25%, 50%, 75%, and 100%); as a control comparison of recent therapy, donepezil was used. In addition, cells with the administration of TMT 10 µM were run as a positive control. Cell viability assay (CCK-8) and enzyme-linked immunosorbent assay (ELISA) were performed to identify the viability and expression of interleukin-1β (IL-1β), caspase-3, and caspase-9 for both PC12 and SH-SY5Y cells. The results showed that BUVEC-CM could significantly reduce IL-1β expression and downregulate caspase-3 and caspase-9, as well as when compared to the donepezil group. Taken together, these results indicate that BUVEC-CM can be used as a potential candidate for neuroprotective agents by reducing the activity of IL-1β and the expression of caspase-9 and caspase-3 in PC12 and SH-SY5Y cells induced by TMT. However, further research still needs to be conducted.https://www.mdpi.com/2306-7381/9/2/48BUVEC-CMneurodegenerationneuroprotectiveapoptosis |
spellingShingle | Vinny A. Larasati Gregorius V. Lembang Yudy Tjahjono Sugi Winarsih Ika Dewi Ana Hevi Wihadmadyatami Dwi L. Kusindarta In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1β, Caspase-3, and Caspase-9 Expression Veterinary Sciences BUVEC-CM neurodegeneration neuroprotective apoptosis |
title | In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1β, Caspase-3, and Caspase-9 Expression |
title_full | In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1β, Caspase-3, and Caspase-9 Expression |
title_fullStr | In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1β, Caspase-3, and Caspase-9 Expression |
title_full_unstemmed | In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1β, Caspase-3, and Caspase-9 Expression |
title_short | In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1β, Caspase-3, and Caspase-9 Expression |
title_sort | in vitro neuroprotective effect of the bovine umbilical vein endothelial cell conditioned medium mediated by downregulation of il 1β caspase 3 and caspase 9 expression |
topic | BUVEC-CM neurodegeneration neuroprotective apoptosis |
url | https://www.mdpi.com/2306-7381/9/2/48 |
work_keys_str_mv | AT vinnyalarasati invitroneuroprotectiveeffectofthebovineumbilicalveinendothelialcellconditionedmediummediatedbydownregulationofil1bcaspase3andcaspase9expression AT gregoriusvlembang invitroneuroprotectiveeffectofthebovineumbilicalveinendothelialcellconditionedmediummediatedbydownregulationofil1bcaspase3andcaspase9expression AT yudytjahjono invitroneuroprotectiveeffectofthebovineumbilicalveinendothelialcellconditionedmediummediatedbydownregulationofil1bcaspase3andcaspase9expression AT sugiwinarsih invitroneuroprotectiveeffectofthebovineumbilicalveinendothelialcellconditionedmediummediatedbydownregulationofil1bcaspase3andcaspase9expression AT ikadewiana invitroneuroprotectiveeffectofthebovineumbilicalveinendothelialcellconditionedmediummediatedbydownregulationofil1bcaspase3andcaspase9expression AT heviwihadmadyatami invitroneuroprotectiveeffectofthebovineumbilicalveinendothelialcellconditionedmediummediatedbydownregulationofil1bcaspase3andcaspase9expression AT dwilkusindarta invitroneuroprotectiveeffectofthebovineumbilicalveinendothelialcellconditionedmediummediatedbydownregulationofil1bcaspase3andcaspase9expression |